Physician profile
Ashley Baize
NPI 1154061497
$2,992.47
in general payments reported to CMS, 2019-2025
30 companies · $935 in 2025
The $935 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $325 · 2023: $757 · 2024: $975 · 2025: $935.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,667.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,667.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $375.84 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Astellas Pharma US INC | $243.10 | 2023-2025 | Veozah, Myrbetriq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $234.12 | 2022-2025 | Jardiance |
| Lilly USA, LLC | $233.23 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $201.98 | 2022-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Pfizer INC. | $175.40 | 2022-2025 | |
| Exact Sciences Corporation | $158.08 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbvie INC. | $156.98 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $138.73 | 2023-2024 | Gardasil 9, Belsomra, Steglatro |
| Radius Health, INC. | $118.60 | 2023-2025 | Tymlos |
| Dexcom, INC. | $116.65 | 2022-2024 | Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals LP | $111.92 | 2024-2025 | Farxiga, Breztri |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $97.42 | 2022-2025 | Xifaxan |
| Axsome Therapeutics, INC. | $87.31 | 2024-2025 | Auvelity, Sunosi |
| Otsuka America Pharmaceutical, INC. | $86.35 | 2022-2025 | Rexulti |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $67.11 | 2023-2024 | Jornay Pm |
| Bayer Healthcare Pharmaceuticals INC. | $65.04 | 2024-2025 | |
| Ibsa Pharma INC. | $44.58 | 2022-2025 | Licart, Tirosint, Flector |
| Organon LLC | $43.71 | 2023-2025 | Nexplanon |
| Phathom Pharmaceuticals, INC. | $33.56 | 2025 | Voquezna |
| Kowa Pharmaceuticals America, INC. | $32.48 | 2022-2025 | Zoryve |
| Sanofi-Aventis U.S. LLC | $26.10 | 2022 | |
| Corium, LLC | $21.52 | 2024 | Azstarys |
| Cipher Pharmaceuticals US LLC | $20.42 | 2025 | Natroba, Spinosad |
| Seqirus USA INC | $19.65 | 2025 | Fluad, Flucelvax |
| Axonics, INC. | $18.32 | 2024 | Axonics |
| Dynavax Technologies Corporation | $17.13 | 2024 | Heplisav-B |
| Sanofi Pasteur INC. | $16.40 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $15.38 | 2022 | |
| Aimmune Therapeutics, INC. | $15.36 | 2025 | Zenpep |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Baize listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.